Physician

Anil Kumar Muddada, M.D

According to 2025 Medicare claims, Anil Muddada, M.D (NPI: 1386877751) practices nephrology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (NPI: 1518589803; TIN: 850900392) and primary practice location at 45805-4602. Muddada is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Muddada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 747 traditional Medicare patients, billed 3,574 HCPCS/CPT codes, and received $273,243 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,158 prescription claims across 403 beneficiaries totaling $296,912 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 92 claims. Open Payments data shows 3 records totaling $153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $161,401 to $273,243. Similarly, Part D prescription costs have risen steadily, from $16,500 to $296,912. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $394 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	571	2,271	$161,401
2016	684	3,080	$211,496
2017	716	3,141	$220,032
2018	820	3,048	$225,192
2019	821	3,279	$245,005
2020	766	3,369	$265,984
2021	771	3,112	$262,484
2022	767	3,115	$274,062
2023	788	3,288	$293,264
2024	747	3,574	$273,243

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	414	$16,500
2016	173	1,317	$77,633
2017	246	1,998	$209,699
2018	351	2,111	$205,498
2019	366	2,377	$337,719
2020	370	2,428	$385,943
2021	354	2,120	$285,924
2022	371	2,275	$349,953
2023	406	2,460	$383,224
2024	403	2,158	$296,912

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$172
2018	N/R	N/R	N/R
2019	N/R	13	$1,511
2020	N/R	13	$1,252
2021	N/R	55	$2,086
2022	N/R	89	$4,046
2023	N/R	153	$5,825
2024	N/R	92	$2,856

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	162	197	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	164	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	268	1,420	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	378	487	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	238	270	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	23	1,110	$67,002
Lokelma	Sodium Zirconium Cyclosilicate	52	1,942	$45,411
Veltassa	Patiromer Calcium Sorbitex	24	943	$29,905
Auryxia	Ferric Citrate	24	720	$26,300
Lanthanum Carbonate	Lanthanum Carbonate	20	840	$20,567

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	19	$1,461
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$546
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	15	$370
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$311
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$169

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$153	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil Kumar Muddada, M.D?

Tedicare shows public-source Medicare data for Anil Kumar Muddada, M.D (NPI 1386877751), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil Kumar Muddada, M.D have ACO affiliation data?

Anil Kumar Muddada, M.D is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Anil Kumar Muddada, M.D?

Anil Kumar Muddada, M.D is linked to MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (billing NPI 1518589803) in the available physician profile data.

Does Anil Kumar Muddada, M.D have Open Payments data?

Anil Kumar Muddada, M.D has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.